Maryam Lustberg: A new multi PI R01 for patients living with chemotherapy induced neuropathy
Maryam Lustberg, Director of the Center for Breast Cancer at Smilow Cancer Hospital, shared a post on LinkedIn:
“To address the huge unmet need of patients living with chemotherapy induced neuropathy, there is a new multi PI R01 with Lise Worthen-Chaudhari, The Ohio State University and myself from Yale School of Medicine. Yale Cancer Center testing a modified Argentine tango intervention vs home exercise for breast cancer survivors of all stages experiencing neuropathy based on promising prior R21 results.
Thank you to Martha Carlson as patient advocate expert: Patrick Schnell statistics and Madeleine Hackney Emory University
Our gratitude to The National Institutes of Health National Institute of Aging for supporting over a decade of our collaboration/team science DAANCE RO1
Cc Monica Bertagnolli.”
Dr. Maryam Lustberg is the Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, and Chief of Breast Medical Oncology at Yale Cancer Center. She is also an Associate Professor of Medicine (Medical Oncology). She has been recognized for her patient-focused care with awards that include being rated by Forbes as one of the top breast medical oncologists in the nation and named to the Castle Connolly list of “Regional Top Doctors,” and “Exceptional Women in Medicine” for 2020. Dr. Lustberg is a member of the ASCO Annual Meeting Education Committee, Patient and Survivor Care Education Committee, and Neuropathy Expert Guideline Panel. She is the immediate past President for the International Organization Multinational Association of Supportive Care in Cancer (MASCC). She serves as an Associate Editor for the Journal of Cancer Survivorship.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023